← Leaderboards
Lei Cao
Ohio State University
$8,524,328
Attributed
$9,158,551
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,158,551 · 8
By mechanism
R01$7,125,013 · 4
R42$974,604 · 1
R56$390,000 · 1
R21$375,092 · 1
R41$293,842 · 1
Top collaborators
- Al Hawkins2 shared
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingFatty Acid Glycerol EstersLeptinObesityBrainAdipocytesPhenotypeEnvironmental Enrichment For Laboratory AnimalsCognitiveHousingMental HealthSocialAdipose TissueMalignant NeoplasmsBrain-Derived Neurotrophic FactorHypothalamic StructureGene TransferGrowthEnvironmentGeneticAdiponectinPreventAnimalsMelanoma
Grant awards (27)
Novel Adipose Targeted Gene Therapy for Lipodystrophy$974,604
R42 · FY2025 · DK
Next generation of AAV vector targeting adipose tissue$487,463
R01 · FY2025 · DK · contact PI
Next generation of AAV vector targeting adipose tissue$487,463
R01 · FY2024 · DK · contact PI
Novel Adipose Targeted Gene Therapy for Lipodystrophy$293,842
R41 · FY2023 · DK
Cancer prevention and treatment by activation of a brain-adipocyte axis$363,090
R01 · FY2022 · CA · contact PI
Cancer prevention and treatment by activation of a brain-adipocyte axis$370,500
R01 · FY2021 · CA · contact PI
Cancer prevention and treatment by activation of a brain-adipocyte axis$370,500
R01 · FY2020 · CA · contact PI
The role of hypothalamic-sympathoneural-adipocyte axis in healthy aging$390,000
R56 · FY2019 · AG · contact PI
Cancer prevention and treatment by activation of a brain-adipocyte axis$359,385
R01 · FY2019 · CA · contact PI
Cancer prevention and treatment by activation of a brain-adipocyte axis$369,313
R01 · FY2018 · CA · contact PI
Cancer Prevention and Treatment by Activation of a Brain-Adipocyte Axis$319,550
R01 · FY2017 · CA · contact PI
The role of hypothalamic-sympathoneural-adipocyte axis in healthy aging$315,700
R01 · FY2017 · AG · contact PI
Identifying brain mediators distinguishing eustress and distress impact on cancer$234,465
R01 · FY2017 · CA · contact PI
Cancer Prevention and Treatment by Activation of a Brain-Adipocyte Axis$319,550
R01 · FY2016 · CA · contact PI
The role of hypothalamic-sympathoneural-adipocyte axis in healthy aging$315,700
R01 · FY2016 · AG · contact PI
Identifying brain mediators distinguishing eustress and distress impact on cancer$234,465
R01 · FY2016 · CA · contact PI
Cancer Prevention and Treatment by Activation of a Brain-Adipocyte Axis$319,550
R01 · FY2015 · CA · contact PI
The role of hypothalamic-sympathoneural-adipocyte axis in healthy aging$306,229
R01 · FY2015 · AG · contact PI
Identifying brain mediators distinguishing eustress and distress impact on cancer$234,465
R01 · FY2015 · CA · contact PI
The role of hypothalamic-sympathoneural-adipocyte axis in healthy aging$315,614
R01 · FY2014 · AG · contact PI
Cancer Prevention and Treatment by Activation of a Brain-Adipocyte Axis$309,460
R01 · FY2014 · CA · contact PI
Identifying brain mediators distinguishing eustress and distress impact on cancer$227,248
R01 · FY2014 · CA · contact PI
Modulating cancer progression by adipogenic human adenovirus type 36$167,170
R21 · FY2014 · CA · contact PI
Cancer Prevention and Treatment by Activation of a Brain-Adipocyte Axis$317,475
R01 · FY2013 · CA · contact PI
The role of hypothalamic-sympathoneural-adipocyte axis in healthy aging$314,505
R01 · FY2013 · AG · contact PI
Identifying brain mediators distinguishing eustress and distress impact on cancer$233,323
R01 · FY2013 · CA · contact PI
Modulating cancer progression by adipogenic human adenovirus type 36$207,922
R21 · FY2013 · CA · contact PI